4.3 Article

Differential activation of adrenal, renal, and lumbar sympathetic nerves following stimulation of the rostral ventrolateral medulla of the rat

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpregu.00713.2010

关键词

blood pressure regulation; brain stem; sympathetic nerve activity

资金

  1. American Heart Association [09PRE2050230-NAM]
  2. National Institutes of Health [R21HL-089364, R01HL096787-PJM, F30 HL105003-NAM, R01HL-67814-TJS]

向作者/读者索取更多资源

Mueller PJ, Mischel NA, Scislo TJ. Differential activation of adrenal, renal, and lumbar sympathetic nerves following stimulation of the rostral ventrolateral medulla of the rat. Am J Physiol Regul Integr Comp Physiol 300: R1230-R1240, 2011. First published February 23, 2011; doi:10.1152/ajpregu.00713.2010.-Under acute and chronic conditions, the sympathetic nervous system can be activated in a differential and even selective manner. Activation of the rostral ventrolateral medulla (RVLM) has been implicated in differential control of sympathetic outputs based on evidence primarily in the cat. Although several studies indicate that differential control of sympathetic outflow occurs in other species, only a few studies have addressed whether the RVLM is capable of producing varying patterns of sympathetic activation in the rat. Therefore, the purpose of the present study was to determine whether activation of the RVLM results in simultaneous and differential increases in preganglionic adrenal (pre-ASNA), renal (RSNA), and lumbar (LSNA) sympathetic nerve activities. In urethane-chloralose anesthetized rats, pre-ASNA, RSNA, and LSNA were recorded simultaneously in all animals. Microinjections of selected concentrations and volumes of glutamate increased pre-ASNA, RSNA, and LSNA concurrently and differentially. Pre-ASNA and RSNA (in most cases) exhibited greater increases compared with LSNA on a percentage basis. By varying the volume or location of the glutamate microinjections, we also identified individual examples of differential and selective activation of these nerves. Decreases in arterial pressure or bilateral blockade of RVLM GABA(A) receptors also revealed differential activation, with the latter having a 3- to 4-fold greater effect on sympathetic activity. Our data provide evidence that activation of the rat RVLM increases renal, lumbar, and preganglionic adrenal sympathetic nerve activities concurrently, differentially, and, in some cases, selectively.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cardiac & Cardiovascular Systems

(In)activity-related neuroplasticity in brainstem control of sympathetic outflow: unraveling underlying molecular, cellular, and anatomical mechanisms

Nicholas A. Mischel, Madhan Subramanian, Maryetta D. Dombrowski, Ida J. Llewellyn-Smith, Patrick J. Mueller

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)

Letter Pharmacology & Pharmacy

Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series

Nicholas Mischel, Christian Bjerre-Real, Jonathan Komisar, Brian Ginsberg, Steven T. Szabo, Xavier Preud'Homme

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)

Article Neurosciences

Physical (In)Activity-Dependent Structural Plasticity in Bulbospinal Catecholaminergic Neurons of Rat Rostral Ventrolateral Medulla

Nicholas A. Mischel, Ida J. Llewellyn-Smith, Patrick J. Mueller

JOURNAL OF COMPARATIVE NEUROLOGY (2014)

Letter Behavioral Sciences

Theta Burst for Cognitive Remediation in Schizophrenia A Case Series and Feasibility Study

Gopalkumar Rakesh, Nicholas A. Mischel, Bruce Luber, Richard S. E. Keefe, Sara Emory, Sarah H. Lisanby, Steven T. Szabo

JOURNAL OF ECT (2020)

Editorial Material Pharmacology & Pharmacy

Esketamine A Drug to Treat Resistant Depression That Brings More Questions Than Answers

Nicholas A. Mischel, Richard Balon

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)

Review Psychiatry

Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress

Michael D. Kritzer, Nicholas A. Mischel, Jonathan R. Young, Christopher S. Lai, Prakash S. Masand, Steven T. Szabo, Sanjay J. Mathew

Summary: Ketamine has evolved from an anesthetic to a rapid treatment for mood disorders and suicidal ideation. Evidence supports its effectiveness in treating depression and suicidality, with potential benefits for anxiety and PTSD, but further research is needed. Intranasal esketamine has been FDA-approved for depression treatment, highlighting recent developments in the field.

ANNALS OF CLINICAL PSYCHIATRY (2021)

Meeting Abstract Biochemistry & Molecular Biology

Activation of the Rostral Ventrolateral Medulla Reveals Specialized Control of Sympathetic Nerves Involved in Regulation of Blood Glucose and Blood Pressure

Soumya Kulkarni, Nicholas Mischel, Patrick Mueller

FASEB JOURNAL (2021)

Article Psychiatry

Non-N-methyl-D-aspartate Autoimmune Encephalopathy and Catatonia Treated With Electroconvulsive Therapy: A Pediatric Case Series and Treatment Guidelines

Nicholas A. Mischel, GenaLynne C. Mooneyham, Cecilia Lau, Heather Van Mater, Richard D. Weiner

PSYCHOSOMATICS (2020)

Meeting Abstract Neurosciences

The Rapid Mood Screener: A Novel and Pragmatic Screener Tool for Bipolar I Disorder

Katherine Thomashow, Cynthia Arfken, Nicholas Mischel

NEUROPSYCHOPHARMACOLOGY (2020)

Letter Behavioral Sciences

Effect of Extended Release Bupropion on Unilateral Ultrabrief Electroconvulsive Therapy Seizure Parameters in Major Depressive Disorder

Gopalkumar Rakesh, Nicholas A. Mischel, Grace Gunderson-Falcone, Amanda Anderson, Denna Copeland, Steven T. Szabo, Richard D. Weiner

JOURNAL OF ECT (2020)

Review Psychiatry

Pharmacological agents to treat severe neuropsychiatric symptoms in major neurocognitive disorders

Nicholas Mischel, Gopalkumar Rakesh, Sanjay Gupta, Andrew Muzyk, Prakash Masand

ANNALS OF CLINICAL PSYCHIATRY (2020)

Meeting Abstract Neurosciences

The Microbiome-Immune-Brain Axis and Cognitive Side Effects of Electroconvulsive Therapy

Jonathan Young, Michael Kritzer, Nicholas Mischel, Jeffrey Taekman, Richard Weiner

BIOLOGICAL PSYCHIATRY (2020)

Review Substance Abuse

Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature

Jonathan R. Young, Shayan A. Smani, Nicholas A. Mischel, Michael D. Kritzer, Lawrence G. Appelbaum, Ashwin A. Patkar

JOURNAL OF ADDICTIVE DISEASES (2020)

Review Pharmacology & Pharmacy

Updates on Preclinical and Translational Neuroscience of Mood Disorders A Brief Historical Focus on Ketamine for the Clinician

Nicholas A. Mischel, Michael D. Kritzer, Ashwin A. Patkar, Prakash S. Masand, Steven T. Szabo

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)

暂无数据